Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 193-204 of 1376 results.
"With good line guard use compliance and no other practice changes occurring simultaneously, findings suggest a line guard is a promising addition to CLABSI prevention bundles, especially for patients at highest risk of external contamination to their lines" Lulgjuraj et al (2025).
"The incidence of CRBSI in our cohort was low, likely due to the implementation of preventive protocols for insertion and maintenance of tunneled central venous catheters" Furlan et al (2025).
"This article provides an explanation of NFD design and functions, guidance and information about their benefits when used correctly, as well as advice on preventing possible complications associated with their use" Munoz-Mozas (2025).
"In community hospital care scenarios, the cost advantage of antimicrobial-coated PICCs remained. Thus, the antimicrobial-coated PICC strategy was cost-saving, providing equal or improved health outcomes at lower costs in China's medical center and community hospitals, making it a more efficient choice for long-term vascular access" Xu et al (2025).
"We aimed to determine the incidence rates of DVT and its contributing factors. Patients with temporary non-tunneled HDCs placed for maintenance HD (on an emergency basis or until the maturation of arteriovenous fistula (AVF)) were followed-up for 3 months" Palakkool et al (2025).
"To identify the evidence base for current aseptic practice in the administration of PN and association with incidence of CRBSI" Fletcher et al (2025).
"To investigate the effect of vascular imaging using near-infrared (NIR) light and transilluminator devices on pain, fear of pain, and patient satisfaction during peripheral intravenous cannulation (PIVC) insertion" Yılmaz et al (2025).
"Ethyl chloride spray significantly reduced pain perception during intravenous cannulation. High levels of patient satisfaction and nurse endorsement for pain management during IV cannulation" Jelly et al (2025).
"Recent research has indicated that a new type of medical device, the force-activated separation device (FASD), may reduce these mechanical complications by 46%, but efficacy and safety data are lacking. The objective of this study was to investigate the efficacy and rate of adverse events (AEs) using a novel FASD" Blacker et al (2025).
"This narrative review examines the existing literature on CVC management post-HSCT, highlighting key factors influencing the removal timing, such as patient characteristics, disease-specific considerations, and institutional practices" Cook et al (2025).
"We aimed to introduce a mixed methods approach to identify off-label indications for antimicrobials in specific settings, and applied this to an antimicrobial not commonly used in the Netherlands, ceftaroline" Stoorvogel et al (2025).
"For breast cancer patients, the ultrasound-guided AxV approach for TIVAP provides superior early postoperative comfort, long-term cosmetic results, and patient satisfaction without increasing early complication risks, representing a significant patient-centered advancement in venous access" He et al (2025).
